Expanding on Data Surrounding Isatuximab Plus Pomalidomide/Dexamethasone in R/R Myeloma
Simon J. Harrison, MD, gives key takeaways from his presentation on the ICARIA-MM study, which he recently presented at the 2019 International Myeloma Workshop.<br />